{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:52:15Z","timestamp":1784890335012,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003790","name":"Hiroshima University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003790","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As the relationship between oral microbiota and treatment efficacy in esophageal cancer remains unexplored, we aimed to clarify it using metagenomic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Of the 140 consecutive patients with esophageal squamous cell carcinoma (ESCC) who underwent esophagectomy with R0 resection at Hiroshima University Hospital between April 2020 and May 2024, 74 who received neoadjuvant therapy were included in this study. 16S rRNA gene from oral tongue coating samples was amplified using polymerase chain reaction and subjected to next-generation sequencing. The oral microbiome data were analyzed using QIIME2 and linear discriminant analysis effect size, and the relationship between the oral microbiota and treatment efficacy and prognosis was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Alpha diversity of the oral microbiota was significantly correlated with the pathological response. Univariate and multivariate analyses showed that the alpha diversity of the oral microbiome (high versus low) was a significant predictor of a good pathological response. Patients with high alpha diversity had significantly improved recurrence-free survival and overall survival compared with those with low alpha diversity. Furthermore, eight bacterial groups (\n                      <jats:italic>Lactobacillales<\/jats:italic>\n                      ,\n                      <jats:italic>Peptostreptococcales-Tissierellales<\/jats:italic>\n                      ,\n                      <jats:italic>Bifidobacteriaceae<\/jats:italic>\n                      ,\n                      <jats:italic>Erysipelotrichaceae<\/jats:italic>\n                      ,\n                      <jats:italic>Lactobacillaceae<\/jats:italic>\n                      ,\n                      <jats:italic>Anaerovoracaceae<\/jats:italic>\n                      ,\n                      <jats:italic>Staphylococcaceae<\/jats:italic>\n                      , and\n                      <jats:italic>Aerococcaceae<\/jats:italic>\n                      ) were significantly more abundant in individuals who responded well to neoadjuvant therapy and two bacterial groups (\n                      <jats:italic>Streptococcaceae<\/jats:italic>\n                      and\n                      <jats:italic>Corynebacteriaceae<\/jats:italic>\n                      ) were significantly more abundant in poor responders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results demonstrate a correlation between the oral microbiome and ESCC treatment efficacy, suggesting that it is a significant prognostic factor. Our findings may also help predict the efficacy of esophageal cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-025-18945-8","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T13:49:13Z","timestamp":1768225753000},"page":"3203-3213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relationship Between the Oral Microbiome and Treatment Efficacy in Esophageal Squamous Cell Carcinoma"],"prefix":"10.1245","volume":"33","author":[{"given":"Manato","family":"Ohsawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-9886","authenticated-orcid":false,"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Hamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Emi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Komatsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"18945_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"key":"18945_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381:400\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(12)60643-6.","journal-title":"Lancet."},{"key":"18945_CR3","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1112088.","journal-title":"N Engl J Med."},{"key":"18945_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","volume":"12","author":"KM Sjoquist","year":"2011","unstructured":"Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681\u201392. https:\/\/doi.org\/10.1016\/S1470-2045(11)70142-5.","journal-title":"Lancet Oncol."},{"key":"18945_CR5","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1002\/cncr.24390","volume":"115","author":"H Miyata","year":"2009","unstructured":"Miyata H, Yoshioka A, Yamasaki M, et al. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer. 2009;115:3324\u201334. https:\/\/doi.org\/10.1002\/cncr.24390.","journal-title":"Cancer."},{"key":"18945_CR6","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","volume":"23","author":"AC Berger","year":"2005","unstructured":"Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005;23:4330\u20137. https:\/\/doi.org\/10.1200\/JCO.2005.05.017.","journal-title":"J Clin Oncol."},{"key":"18945_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016\u201322. https:\/\/doi.org\/10.1038\/nm.2015.","journal-title":"Nat Med."},{"key":"18945_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur JC, Perez-Chanona E, M\u00fchlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338:120\u20133. https:\/\/doi.org\/10.1126\/science.1224820.","journal-title":"Science."},{"key":"18945_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"342","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967\u201370. https:\/\/doi.org\/10.1126\/science.1240527.","journal-title":"Science."},{"key":"18945_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137. https:\/\/doi.org\/10.1126\/science.aan3706.","journal-title":"Science."},{"key":"18945_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jacep.2022.08.018","volume":"9","author":"S Miyauchi","year":"2023","unstructured":"Miyauchi S, Nishi H, Ouhara K, et al. Relationship between periodontitis and atrial fibrosis in atrial fibrillation: Histological evaluation of left atrial appendages. JACC Clin Electrophysiol. 2023;9:43\u201353. https:\/\/doi.org\/10.1016\/j.jacep.2022.08.018.","journal-title":"JACC Clin Electrophysiol."},{"key":"18945_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/cei.13430","volume":"200","author":"H Nishi","year":"2020","unstructured":"Nishi H, Hosomi N, Ohta K, et al. Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke. Clin Exp Immunol. 2020;200:302\u20139. https:\/\/doi.org\/10.1111\/cei.13430.","journal-title":"Clin Exp Immunol."},{"key":"18945_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/epirev\/mxx006","volume":"39","author":"DS Michaud","year":"2017","unstructured":"Michaud DS, Fu Z, Shi J, Chung M. Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev. 2017;39:49\u201358. https:\/\/doi.org\/10.1093\/epirev\/mxx006.","journal-title":"Epidemiol Rev."},{"key":"18945_CR14","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jamaoncol.2024.4006","volume":"10","author":"S Kwak","year":"2024","unstructured":"Kwak S, Wang C, Usyk M, et al. Oral microbiome and subsequent risk of head and neck squamous cell cancer. JAMA Oncol. 2024;10:1537\u201347. https:\/\/doi.org\/10.1001\/jamaoncol.2024.4006.","journal-title":"JAMA Oncol."},{"key":"18945_CR15","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1158\/0008-5472.CAN-17-1296","volume":"77","author":"BA Peters","year":"2017","unstructured":"Peters BA, Wu J, Pei Z, et al. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017;77:6777\u201387. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1296.","journal-title":"Cancer Res."},{"key":"18945_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/microorganisms8020308","volume":"8","author":"JR Willis","year":"2020","unstructured":"Willis JR, Gabald\u00f3n T. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms. 2020;8:308. https:\/\/doi.org\/10.3390\/microorganisms8020308.","journal-title":"Microorganisms."},{"key":"18945_CR17","volume-title":"International Union Against Cancer (UICC): TNM classification of malignant tumors","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. International Union Against Cancer (UICC): TNM classification of malignant tumors. Hoboken: Wiley-Blackwell; 2017."},{"key":"18945_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205\u201316. https:\/\/doi.org\/10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst."},{"key":"18945_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10388-024-01048-w","volume":"21","author":"Y Doki","year":"2024","unstructured":"Doki Y, Tanaka K, Kawachi H, et al. Japanese Classification of Esophageal Cancer, 12th edition: Part II. Esophagus. 2024;21:216\u201369. https:\/\/doi.org\/10.1007\/s10388-024-01048-w.","journal-title":"Esophagus."},{"key":"18945_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","volume":"404","author":"K Kato","year":"2024","unstructured":"Kato K, Machida R, Ito Y, et al. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial. Lancet. 2024;404:55\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(24)00745-1.","journal-title":"Lancet."},{"key":"18945_CR21","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.athoracsur.2015.02.042","volume":"99","author":"Y Hamai","year":"2015","unstructured":"Hamai Y, Hihara J, Emi M, et al. Results of neoadjuvant chemoradiotherapy with docetaxel and 5-fluorouracil followed by esophagectomy to treat locally advanced esophageal cancer. Ann Thorac Surg. 2015;99:1887\u201393. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.02.042.","journal-title":"Ann Thorac Surg."},{"key":"18945_CR22","doi-asserted-by":"publisher","first-page":"19103","DOI":"10.1038\/s41598-023-46566-2","volume":"13","author":"L Simeng","year":"2023","unstructured":"Simeng L, Enyao L, Zhenyu S, et al. Altered gut microbiota and short-chain fatty acids in Chinese children with constipated autism spectrum disorder. Sci Rep. 2023;13:19103. https:\/\/doi.org\/10.1038\/s41598-023-46566-2.","journal-title":"Sci Rep."},{"key":"18945_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170:548-563.e16. https:\/\/doi.org\/10.1016\/j.cell.2017.07.008.","journal-title":"Cell."},{"key":"18945_CR24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2017.03.040","volume":"169","author":"TA Scott","year":"2017","unstructured":"Scott TA, Quintaneiro LM, Norvaisas P, et al. Hosts-microbe co-metabolism dictates cancer drug efficacy in C. elegans. Cell. 2017;169:442-56.e18. https:\/\/doi.org\/10.1016\/j.cell.2017.03.040.","journal-title":"Cell."},{"key":"18945_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou M, Pitt JM, Daill\u00e8re R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079\u201384. https:\/\/doi.org\/10.1126\/science.aad1329.","journal-title":"Science."},{"key":"18945_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2020.00511","volume":"11","author":"TE Van Dyke","year":"2020","unstructured":"Van Dyke TE, Bartold PM, Reynolds EC. The nexus between periodontal inflammation and dysbiosis. Front Immunol. 2020;11:511. https:\/\/doi.org\/10.3389\/fimmu.2020.00511.","journal-title":"Front Immunol."},{"key":"18945_CR27","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/cancers13092124","volume":"13","author":"SY Park","year":"2021","unstructured":"Park SY, Hwang BO, Lim M, et al. Oral gut microbiome axis in gastrointestinal disease and cancer. Cancers (Basel). 2021;13:2124. https:\/\/doi.org\/10.3390\/cancers13092124.","journal-title":"Cancers (Basel)."},{"key":"18945_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/cncr.33316","volume":"127","author":"M Kawasaki","year":"2021","unstructured":"Kawasaki M, Ikeda Y, Ikeda E, et al. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer. 2021;127:512\u20139. https:\/\/doi.org\/10.1002\/cncr.33316.","journal-title":"Cancer."},{"key":"18945_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40168-016-0218-6","volume":"4","author":"BA Peters","year":"2016","unstructured":"Peters BA, Dominianni C, Shapiro JA, et al. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome. 2016;4:69. https:\/\/doi.org\/10.1186\/s40168-016-0218-6.","journal-title":"Microbiome."},{"key":"18945_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178:795-806.e12. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008.","journal-title":"Cell."},{"issue":"359","key":"18945_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"5","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;5(359):97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236.","journal-title":"Science."},{"key":"18945_CR32","doi-asserted-by":"publisher","first-page":"1040424","DOI":"10.3389\/fmolb.2022.1040424","volume":"9","author":"F Shoji","year":"2022","unstructured":"Shoji F, Yamaguchi M, Okamoto M, et al. Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer. Front Mol Biosci. 2022;9:1040424. https:\/\/doi.org\/10.3389\/fmolb.2022.1040424.","journal-title":"Front Mol Biosci."},{"key":"18945_CR33","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jgh.15941","volume":"37","author":"MK Cheung","year":"2022","unstructured":"Cheung MK, Yue GGL, Lauw S, et al. Alterations in gut microbiota of esophageal squamous cell carcinoma patients. J Gastroenterol Hepatol. 2022;37:1919\u201327. https:\/\/doi.org\/10.1111\/jgh.15941.","journal-title":"J Gastroenterol Hepatol."},{"key":"18945_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1349-7006.2004.tb02488.x","volume":"95","author":"M Narikiyo","year":"2004","unstructured":"Narikiyo M, Tanabe C, Yamada Y, et al. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004;95:569\u201374. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb02488.x.","journal-title":"Cancer Sci."},{"key":"18945_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084\u20139. https:\/\/doi.org\/10.1126\/science.aac4255.","journal-title":"Science."},{"key":"18945_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijfoodmicro.2009.12.023","volume":"138","author":"P L\u00f3pez","year":"2010","unstructured":"L\u00f3pez P, Gueimonde M, Margolles A, Su\u00e1rez A. Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol. 2010;138:157\u201365. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2009.12.023.","journal-title":"Int J Food Microbiol."},{"key":"18945_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/01635589609514492","volume":"26","author":"BL Pool-Zobel","year":"1996","unstructured":"Pool-Zobel BL, Neudecker C, Domizlaff I, et al. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer. 1996;26:365\u201380. https:\/\/doi.org\/10.1080\/01635589609514492.","journal-title":"Nutr Cancer."},{"key":"18945_CR38","doi-asserted-by":"publisher","first-page":"114283","DOI":"10.1016\/j.intimp.2025.114283","volume":"150","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wu J, Cai K, et al. Bifidobacterium longum subsp. longum XZ01 delays the progression of colon cancer in mice through the interaction between the microbial spatial distribution and tumour immunity. Int Immunopharmacol. 2025;150:114283. https:\/\/doi.org\/10.1016\/j.intimp.2025.114283.","journal-title":"Int Immunopharmacol."},{"key":"18945_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41698-025-00810-2","volume":"9","author":"H Wang","year":"2025","unstructured":"Wang H, You W, Zhu Z, et al. Streptococcus lutetiensis inhibits CD8+ IL17A+ TRM cells and leads to gastric cancer progression and poor prognosis. NPJ Precis Oncol. 2025;9:43. https:\/\/doi.org\/10.1038\/s41698-025-00810-2.","journal-title":"NPJ Precis Oncol."},{"key":"18945_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.immuni.2013.10.002","volume":"39","author":"PM Smith","year":"2013","unstructured":"Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate the differentiation and function of regulatory T cells via histone deacetylase inhibition. Immunity. 2013;39:841\u201353. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.002.","journal-title":"Immunity."},{"key":"18945_CR41","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41416-020-01198-5","volume":"124","author":"Y Liu","year":"2021","unstructured":"Liu Y, Baba Y, Ishimoto T, et al. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma. Br J Cancer. 2021;124:963\u201374. https:\/\/doi.org\/10.1038\/s41416-020-01198-5.","journal-title":"Br J Cancer."},{"key":"18945_CR42","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/sj.bdj.2016.865","volume":"221","author":"M Kilian","year":"2016","unstructured":"Kilian M, Chapple ILC, Hannig M, et al. The oral microbiome\u2014An update for oral healthcare professionals. Br Dental J. 2016;221:657\u201366. https:\/\/doi.org\/10.1038\/sj.bdj.2016.865.","journal-title":"Br Dental J."},{"issue":"10","key":"18945_CR43","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/jcpe.12995","volume":"45","author":"MM Invernici","year":"2018","unstructured":"Invernici MM, Salvador SL, Silva PHF, et al. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: a randomized clinical trial. J Clin Periodontol. 2018;45(10):1198\u2013210. https:\/\/doi.org\/10.1111\/jcpe.12995.","journal-title":"J Clin Periodontol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18945-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18945-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:09Z","timestamp":1773330489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18945-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18945"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18945-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board of Hiroshima University approved the study protocol (approval number: E-1874), and written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}